Pathophysiology and Neuroprotective Strategies in Hypoxic-Ischemic Brain Injury and Stroke
- PMID: 28829350
- PMCID: PMC5575630
- DOI: 10.3390/brainsci7080110
Pathophysiology and Neuroprotective Strategies in Hypoxic-Ischemic Brain Injury and Stroke
Abstract
Hypoxic-ischemic brain injury and stroke are closely related and devastating conditions that can affect individuals of all ages.[...].
Conflict of interest statement
Bruno P. Meloni is a holder of several patents regarding the use of arginine-rich peptides as neuroprotective treatments.
References
-
- Feigin V.L., Forouzanfar M.H., Krishnamurthi R., Mensah G.A., Connor M., Bennett D.A., Moran A.E., Sacco R.L., Anderson L., Truelsen T., et al. Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990–2010: Findings from the Global Burden of Disease Study. Lancet. 2014;383:245–254. doi: 10.1016/S0140-6736(13)61953-4. - DOI - PMC - PubMed
-
- Pierrat V., Haouari N., Liska A., Thomas D., Subtil D., Truffer P., Groupe d’Etudes en Epidémiologie Périnatale Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: Population based study. Arch. Dis. Child. Fetal Neonatal Ed. 2005;90:F257–F261. doi: 10.1136/adc.2003.047985. - DOI - PMC - PubMed
-
- Meloni B.P., Craig A.J., Milech N., Hopkins R.M., Watt P.M., Knuckey N.W. The neuroprotective efficacy of cell penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures. Cell. Mol. Neurobiol. 2014;34:173–181. doi: 10.1007/s10571-013-9999-3. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources